Divian founded AEX Capital in July 2017. Prior to this, he held the position of Global Chief Business Officer and CEO (SA) at Cipla Biotech (a subsidiary of Cipla Ltd – India). He is a proven business leader with 18 years international experience in executive management, business development, deal making, corporate and legal strategy, most of which is in the pharmaceutical industry. He has managed executive teams and has concluded deals that span multiple geographies, which include M&A transactions, Strategic Alliances, Partnering, Government Affairs, Licensing and Joint Ventures.
Steven Lehrer is a Board and Senior Management Advisor to Life Science Companies. Steve has over 30 years of experience starting, growing and running life science based businesses focused on commercializing new technology. Steve has extensive experience in pharmaceutical R&D, regulatory and operations, biopharmaceutical R&D, regulatory, operations, commercialization and biosimilars, molecular diagnostics discovery, validation and commercialization, bioinformatics/health care econometrics analysis, health care reimbursement/establishing reimbursement for new medical technology and synthetic biology development and commercialization.
Tamal is the founder of Integrated Biopharma and Pharma Solution (IBPS), a scientific and technical consulting firm and served many MNCs in India, US, Europe, Latin America, China. He also serves as a mentor for the bio-incubator centre of Indian Institute of Technology Kanpur, one of the most acclaimed institutes in India and in the world. Tamal has rich experience in biopharmaceutical development and regulatory strategy having undertaken extensive work in Biologics and Biosimilar product development, non-clinical and clinical development strategy, comparability studies, technology transfer, global regulatory and analytical characterization.
William is a qualified Chartered Accountant. He is currently the Chief Executive Officer and Director of two companies, Blackriver Capital and Tontrac.
Page 1 of 2